We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Janssen Pain Drug Nucynta ER Overcomes Complete Response to Gain Approval
Janssen Pain Drug Nucynta ER Overcomes Complete Response to Gain Approval
August 26, 2011
Ortho-McNeil Janssen pain medication Nucynta ER received the FDA’s go-ahead after the company successfully answered a complete response letter on the formulation change.